FDA MoCRA Compliance: Cosmetic Registration and Product Listing in the United States
The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) marks a major shift in how cosmetic products are regulated in the United States. For cosmetic manufacturers, understanding and meeting these new FDA requirements is essential to maintain market access and avoid regulatory issues. This blog explains the key obligations introduced by MoCRA and how cosmetic companies can achieve full compliance with FDA cosmetic regulations.
What MoCRA Means for Cosmetic Manufacturers
MoCRA establishes new rules for cosmetic facility registration, product listing, safety substantiation, adverse event recordkeeping, serious adverse event reporting, and updated labeling requirements. These changes aim to improve consumer safety and transparency in the U.S. cosmetic market.
Cosmetic companies that manufacture or process products for the U.S. market now face several new obligations:
Cosmetic facility registration with the FDA, renewed every two years
FDA cosmetic product listing through the Cosmetics Direct portal, including detailed product and ingredient information
Appointment of a cosmetic responsible person to ensure compliance with MoCRA requirements
Cosmetic safety substantiation to prove product safety before marketing
Maintaining records of adverse event reporting cosmetics and submitting serious adverse event reports to the FDA
Conducting thorough FDA label review to meet updated labeling standards, including fragrance allergen disclosures
Preparing for Good Manufacturing Practice (GMP) readiness and ongoing FDA inspections
These requirements represent a significant increase in regulatory oversight compared to previous cosmetic FDA regulations.
Cosmetic Facility Registration and Product Listing
Under MoCRA, all cosmetic facilities that manufacture, process, pack, or hold cosmetic products for the U.S. market must register with the FDA. This registration must be renewed every two years to remain valid. The FDA uses this information to monitor facilities and enforce compliance.
In addition to facility registration, cosmetic products must be listed with the FDA through the Cosmetics Direct system. This listing includes:
Product name and category
Ingredient details, including concentrations
Responsible person contact information
Accurate and timely product listing is critical for U.S. cosmetic compliance. Failure to register facilities or list products can result in enforcement actions, including product seizures or import refusals.
Duties of the Cosmetic Responsible Person
MoCRA requires appointing a cosmetic responsible person who acts as the primary contact for FDA communications and ensures compliance with all regulatory obligations. This role includes:
Overseeing facility registration and product listing
Ensuring cosmetic safety substantiation is documented and available
Maintaining adverse event records and submitting serious adverse event reports
Reviewing product labels to meet FDA requirements
Coordinating with manufacturing sites to maintain GMP standards
The cosmetic responsible person plays a vital role in maintaining ongoing compliance and responding to FDA inquiries.
Safety Substantiation and Adverse Event Reporting
One of the most important MoCRA compliance elements is cosmetic safety substantiation. Companies must have adequate evidence that their products are safe for consumers under labeled or customary conditions of use. This may include toxicological data, clinical testing, or scientific literature.
MoCRA also strengthens requirements for adverse event reporting cosmetics. Companies must keep detailed records of any adverse events reported by consumers or healthcare professionals. Serious adverse events must be reported to the FDA within 15 calendar days.
These safety and reporting obligations help protect consumers and provide the FDA with critical information to monitor product safety.
Updated Labeling Requirements and Fragrance Allergens
MoCRA introduces new labeling requirements to improve transparency and consumer awareness. Cosmetic labels must now include:
Clear ingredient listings using FDA-approved nomenclature
Disclosure of 11 specific fragrance allergens when present above threshold levels
Accurate product identity and net quantity statements
The FDA label review process ensures that cosmetic labels meet these updated standards. Companies should conduct thorough label audits to avoid non-compliance risks.
Preparing for GMP Readiness and Ongoing Compliance
While MoCRA does not explicitly mandate GMPs, it requires cosmetic facilities to maintain records and processes consistent with good manufacturing practices. This includes:
Documenting quality control procedures
Ensuring product safety and consistency
Keeping detailed manufacturing and distribution records
Preparing for potential FDA inspections and maintaining GMP readiness is essential for long-term compliance in the U.S. cosmetic market.
How AF Pharma Supports MoCRA Compliance
Navigating the complex FDA MoCRA requirements can be challenging for international cosmetic brands. AF Pharma specializes in regulatory consulting services that help companies achieve full MoCRA compliance and secure U.S. cosmetic market access. Our services include:
Cosmetic facility registration and renewal support
FDA cosmetic product listing through Cosmetics Direct
Cosmetic responsible person designation and compliance management
Cosmetic safety substantiation documentation and review
FDA label review and fragrance allergen preparation
GMP readiness assessment and ongoing regulatory support
With AF Pharma MoCRA expertise, cosmetic manufacturers can confidently meet FDA requirements and avoid costly delays or enforcement actions.
Final Thoughts on MoCRA Compliance for Cosmetics
The Modernization of Cosmetics Regulation Act of 2022 represents a new era in U.S. cosmetic FDA regulations. Cosmetic manufacturers must adapt to facility registration, product listing, safety substantiation, adverse event reporting, and updated labeling rules to maintain market access.
Understanding these obligations and implementing robust compliance programs is essential. Partnering with a knowledgeable regulatory consultant like AF Pharma can simplify the process and ensure your products meet all FDA MoCRA requirements.
Comments